PubRank

S F Wolf

Author PubWeight™ 128.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993 19.80
2 Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991 7.52
3 Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A 1993 6.33
4 Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993 5.71
5 Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993 4.04
6 The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 1996 3.82
7 Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc Natl Acad Sci U S A 1984 3.53
8 Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol 1992 3.15
9 Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol 1994 2.68
10 Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993 2.35
11 Studies of X chromosome DNA methylation in normal human cells. Nature 1982 2.34
12 Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994 2.31
13 Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992 2.26
14 IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol 1995 2.12
15 Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 1994 2.11
16 Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994 1.98
17 Clusters of CpG dinucleotides implicated by nuclease hypersensitivity as control elements of housekeeping genes. Nature 1985 1.96
18 Isolation and characterization of cloned DNA sequences that hybridize to the human X chromosome. Cell 1980 1.96
19 Characterization of a cloned DNA sequence that is present at centromeres of all human autosomes and the X chromosome and shows polymorphic variation. Proc Natl Acad Sci U S A 1984 1.86
20 Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996 1.77
21 IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol 1994 1.75
22 IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994 1.65
23 Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994 1.64
24 Derepression with decreased expression of the G6PD locus on the inactive X chromosome in normal human cells. Cell 1982 1.62
25 IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol 1997 1.61
26 Incomplete X chromosome dosage compensation in chorionic villi of human placenta. Proc Natl Acad Sci U S A 1985 1.53
27 Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A 1994 1.53
28 The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 1988 1.47
29 Complete concordance between glucose-6-phosphate dehydrogenase activity and hypomethylation of 3' CpG clusters: implications for X chromosome dosage compensation. Nucleic Acids Res 1984 1.42
30 IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol 1996 1.42
31 IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 1995 1.40
32 Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 1993 1.32
33 Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 1993 1.31
34 Nuclear metabolism of ribosomal RNA in growing, methionine-limited, and ethionine-treated HeLa cells. Biochemistry 1977 1.24
35 Interleukin-12 gene expression after viral infection in the mouse. J Virol 1995 1.22
36 Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells. Int Immunol 1995 1.17
37 Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity. Eur J Immunol 2001 1.17
38 Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics 1992 1.15
39 Rapid hybridization kinetics of DNA attached to submicron latex particles. Nucleic Acids Res 1987 1.13
40 IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 1995 1.06
41 Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc Natl Acad Sci U S A 1995 1.04
42 Implications for X-chromosome regulation from studies of human X-chromosome DNA. Cold Spring Harb Symp Quant Biol 1983 1.02
43 Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum Gene Ther 1994 1.00
44 Characterization of reiterated human DNA with respect to mammalian X chromosome homology. Somat Cell Mol Genet 1984 0.99
45 Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today 1992 0.97
46 IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells. J Immunol 1995 0.96
47 Interleukin-12 stimulates B cell growth by inducing IFN-gamma. Cell Immunol 1996 0.95
48 Localization of glucose-6-phosphate dehydrogenase in mouse and man by in situ hybridization: evidence for a single locus and transposition of homologous X-linked genes. Cytogenet Cell Genet 1985 0.94
49 Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy. J Infect Dis 1996 0.94
50 Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses. Infect Immun 1998 0.90
51 Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon. J Med Microbiol 2003 0.84
52 Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response. Infect Immun 1999 0.82
53 Hyperexpression of HPRT induced by 5-azacytidine in mouse-human hybrid reactivants. Am J Hum Genet 1985 0.82
54 Evidence for a relationship between DNA methylation and DNA replication from studies of the 5-azacytidine-reactivated allocyclic X chromosome. Exp Cell Res 1985 0.81
55 The use of denaturing gradient gel electrophoresis to screen for DNA sequence polymorphisms in the human factor VIII gene. Electrophoresis 1989 0.81
56 FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction. Eur Respir J 2010 0.80
57 Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses. J Interferon Cytokine Res 2000 0.79
58 A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Int J Oncol 1998 0.79
59 Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy. J Surg Res 1995 0.79
60 A CTL assay requiring only 150 microliter of mouse blood. J Immunol Methods 2000 0.79
61 Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant. Cancer Res 1999 0.78
62 IL-12-Dependent enhancement of CTL response to weak class I-restricted peptide immunogens requires coimmunization with T helper cell immunogens. Clin Immunol 2000 0.78
63 The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy. Immunol Invest 2005 0.78
64 Efficacy and mechanisms of action of rmB7.2-Ig as an antitumor agent in combination with Adriamycin and Cytoxan chemotherapy. Clin Immunol 2001 0.78
65 Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12. Clin Exp Metastasis 1999 0.77
66 Interleukin-12 as vaccine adjuvant. Characteristics of primary, recall, and long-term responses. Ann N Y Acad Sci 1996 0.77
67 The interleukin-12 beta subunit (p40) maps to mouse chromosome 11. Mamm Genome 1996 0.75
68 Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. Mamm Genome 1996 0.75
69 Geochemical and cosmochemical materials. Anal Chem 2001 0.75
70 Geochemical and cosmochemical materials. Anal Chem 1999 0.75
71 Immune response enhancement by in vivo administration of B7.2Ig, a soluble costimulatory protein. Clin Immunol 1999 0.75